-
UnitedHealth CEO Highlights Hospitals, Doctors, Pharma's Role In Soaring Health Care Costs
Thursday, January 16, 2025 - 5:28pm | 578UnitedHealth Group, Inc. (NYSE:UNH) reported its financial results on Thursday after a tumultuous fourth quarter that included the murder of UnitedHealthcare division CEO Brian Thompson and broad public outrage over the nation's health care system. What To Know: UnitedHealth posted mixed...
-
Is Big Pharma Poised To Take Over Cannabis? 3 Companies Already Manage 8 In 10 Drug Prescriptions In The US
Thursday, July 11, 2024 - 3:01pm | 860The U.S. Federal Trade Commission (FTC) recently highlighted the significant influence of pharmacy benefit managers (PBMs) on drug prices due to market consolidation. This trend raises critical questions about the future of the cannabis industry, especially if cannabis is federally legalized. The...
-
What Makes Mylan's Newest EpiPen Lawsuit Different?
Monday, April 10, 2017 - 2:01pm | 900Mylan N.V. (NASDAQ: MYL), which has faced a plethora of lawsuits in the past over its EpiPen, is now being saddled with another lawsuit, although this time around the parties involved go beyond the company and the plaintiffs. EpiPen And Its Legal Tussle EpiPen, or an epinephrine auto injector is...
-
CVS Growth May Have Weakened, But Credit Suisse Still Sees Catalysts
Tuesday, September 20, 2016 - 1:52pm | 488Credit Suisse maintains its Outperform rating on CVS Health Corp (NYSE: CVS) as it sees potential catalysts to drive the top line despite EPS growth that be declining from prior years' peak levels. "Specifically, estimated new PBM business wins, of $7.3 billion, including Medicare lives year to...
-
Benzinga Talks With Imprimis Pharmaceuticals' CEO About Earnings, MKO Melt, Drug Pricing And More
Monday, August 22, 2016 - 9:07am | 708Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) owns, markets and dispenses a portfolio of compounded therapeutic in various areas, including ophthalmology, urology, otolaryngology and infectious diseases. Benzinga had the privilege of chatting with the company's CEO, Mark Baum, about its most recent...
-
Cleveland Research Prefers UnitedHealth, Anthem Over Aetna In Healthcare
Friday, April 8, 2016 - 4:00pm | 506Cleveland Research prefers UnitedHealth Group Inc (NYSE: UNH) and Anthem Inc (NYSE: ANTM) over Aetna Inc (NYSE: AET) in the healthcare space. UnitedHealth: Buy, $155 PT Analyst Steve Willoughby initiated coverage of UnitedHealth with a Buy rating and $155 price target, as his research suggests the...
-
Aetna Buys Coventry Health Care for $5.7 Billion
Monday, August 20, 2012 - 11:14am | 479Health-care giant Aetna (NYSE: AET) has agreed upon terms to purchase Coventry Health Care (NYSE: CVH) for $5.7 billion. The 20 percent premium for Coventry has shares trading north of $40. Aetna, in the meantime is trading up around three percent in Monday morning trading. Aetna's buyout comes...